Article Information
History
- November 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Arjun Chandna1,2,*,
- Raman Mahajan3,
- Priyanka Gautam4,
- Lazaro Mwandigha5,
- Sabine Dittrich2,6,7,
- Vikash Kumar3,
- Jennifer Osborn6,
- Pragya Kumar8,
- Constantinos Koshiaris5,
- George M Varghese4,
- Yoel Lubell2,9 and
- Sakib Burza3,10
- 1Cambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, Cambodia
- 2Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK
- 3Médecins Sans Frontières, New Delhi, India
- 4Department of Infectious Diseases, Christian Medical College, Vellore, India
- 5Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- 6Foundation for Innovative Diagnostics, Geneva, Switzerland
- 7Deggendorf Institut of Technology, European-Campus Rottal Inn, Pfarrkirchen, Germany
- 8Department of Community & Family Medicine, All India Institute of Medical Sciences, Patna, India
- 9Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand
- 10Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK
- ↵*CORRESPONDING AUTHOR
Dr. Arjun Chandna, Cambodia Oxford Medical Research Unit, Siem Reap, Cambodia Tel: +855-85-712-586; Email: arjun{at}tropmedres.ac; arjunchandna{at}gmail.com
Posted November 27, 2022.
Point-of-care prognostication in moderate Covid-19: analytical validation and diagnostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test
